Akero Therapeutics, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Feb. 29, 2024).
In: Drug Week, 2024-03-19, S. 4599
serialPeriodical
Zugriff:
Akero Therapeutics, Inc. has filed a Form S-8 with the U.S. Securities and Exchange Commission (SEC) on February 29, 2024. The form is used for the registration of securities to be offered to the company's employees as part of certain plans. Akero Therapeutics is a healthcare biotechnology company based in South San Francisco, California. The SEC filing is a formal document or financial statement submitted by publicly-traded companies. For more information, the SEC filing can be found at the provided link. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Akero Therapeutics, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Feb. 29, 2024).
|
---|---|
Zeitschrift: | Drug Week, 2024-03-19, S. 4599 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|